X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Procter & Gamble Health Ltd.
BSE CODE: 500126   |   NSE CODE: PGHL   |   ISIN CODE : INE199A01012   |   15-May-2024 Hrs IST
BSE NSE
Rs. 4798.00
48.75 ( 1.03% )
 
Prev Close ( Rs.)
4749.25
Open ( Rs.)
4750.00
 
High ( Rs.)
4809.00
Low ( Rs.)
4727.55
 
Volume
119
Week Avg.Volume
253
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 4788.70
37 ( 0.78% )
 
Prev Close ( Rs.)
4751.70
Open ( Rs.)
4780.50
 
High ( Rs.)
4802.00
Low ( Rs.)
4716.25
 
Volume
4030
Week Avg.Volume
13201
 
52 WK High-Low Range(Rs.)
4636.55
5642.85
Particulars Jun 2023Jun 2022Jun 2021Jun 2020Dec 2018
Operational & Financial Ratios          
   Earnings Per Share (Rs)138.23  115.98  106.51  153.06  61.29  
   CEPS(Rs)155.16  132.29  124.60  170.80  74.01  
   DPS(Rs)95.00  52.50  130.00  230.00  440.00  
   Book NAV/Share(Rs)447.62  366.99  421.59  544.82  927.78  
   Tax Rate(%)26.97  24.02  24.21  28.40  35.60  
Margin Ratios          
   Core EBITDA Margin(%)24.44  22.73  24.39  23.18  16.98  
   EBIT Margin(%)23.71  21.55  23.21  26.17  18.61  
   Pre Tax Margin(%)23.66  21.51  23.13  26.17  18.61  
   PAT Margin (%)17.28  16.35  17.53  18.74  11.98  
   Cash Profit Margin (%)19.39  18.64  20.50  20.91  14.47  
Performance Ratios          
   ROA(%)11.00  9.83  8.65  10.82  4.96  
   ROE(%)33.94  29.41  22.04  20.79  8.95  
   ROCE(%)46.07  38.45  29.08  29.01  13.90  
   Asset Turnover(x)0.64  0.60  0.49  0.58  0.41  
   Sales/Fixed Asset(x)5.27  5.17  4.87  7.04  4.50  
   Working Capital/Sales(x)2.70  3.13  2.07  1.87  0.63  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.19  0.19  0.21  0.14  0.22  
   Receivable days27.36  22.20  28.06  21.73  40.59  
   Inventory Days34.37  36.19  45.68  33.31  58.27  
   Payable days206.35  188.51  177.09  90.99  116.16  
Valuation Parameters          
   PER(x)37.97  36.10  52.52  26.57  50.32  
   PCE(x)33.83  31.65  44.89  23.81  41.67  
   Price/Book(x)11.73  11.41  13.27  7.47  3.32  
   Yield(%)1.81  1.25  2.32  5.65  14.27  
   EV/Net Sales(x)6.73  5.95  8.74  4.51  4.57  
   EV/Core EBITDA(x)24.12  23.59  33.38  15.91  22.47  
   EV/EBIT(x)26.27  26.11  37.67  17.23  24.54  
   EV/CE(x)3.71  3.42  4.46  2.89  1.50  
   M Cap / Sales7.09  6.24  9.21  4.98  6.03  
Growth Ratio          
   Net Sales Growth(%)10.34  10.48  -25.60  59.70  21.61  
   Core EBITDA Growth(%)22.15  6.34  -31.27  122.73  70.76  
   EBIT Growth(%)24.11  8.42  -34.03  124.62  59.70  
   PAT Growth(%)19.19  8.89  -30.42  149.73  66.68  
   EPS Growth(%)19.19  8.89  -30.42  149.73  66.68  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  0.00  0.00  0.00  0.00  
   Current Ratio(x)1.72  1.62  1.89  2.35  3.45  
   Quick Ratio(x)1.53  1.43  1.67  2.10  3.24  
   Interest Cover(x)409.05  604.26  292.60  0  0  
   Total Debt/Mcap(x)0.00  0.00  0.00  0.00  0.00